𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon

✍ Scribed by T. Gjørup; O. J. Hartling; H. Kelbæk; S. L. Nielsen

Publisher
Springer
Year
1986
Tongue
English
Weight
301 KB
Volume
31
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind placebo-controlled trial
A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
✍ K. Wesnes; D. Simmons; M. Rook; P. Simpson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 826 KB

Fifty-four elderly patients, living at home, completed a 3-month, double-blind, randomized, placebo-controlled trial of the effects of Tanakan on both cognitive efficiency and the quality of life. Patients were included in the study if they showed mild signs of impairment in everyday function on the

Oral iloprost treatment in patients with
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study
✍ Fredrick M. Wigley; Joseph H. Korn; M. E. Csuka; Thomas A. Medsger Jr.; Naomi F. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

## Objective: To evaluate the efficacy and tolerability of an oral preparation of iloprost, a prostacyclin analog, in patients with raynaud's phenomenon (rp) secondary to systemic sclerosis (scleroderma). ## Methods: A multicenter, randomized, parallel-group, placebo-controlled double-blind study

Nicardipine in the treatment of raynaud'
Nicardipine in the treatment of raynaud's phenomenon
✍ Fredrick M. Wigley; Robert A. Wise; Raymond Malamet; Thomas E. Scott 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

A new calcium channel blocker, nicardipine, was studied for treatment of Raynaud's phenomenon in a double-blind, placebo-controlled, crossover trial during the winter months. Clinical response was assessed by a patient-kept diary of symptoms and finger systolic pressure that was measured at room tem

Prevention of vascular damage in sclerod
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
✍ A. E. Gliddon; C. J. Doré; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t

A double-blind placebo-controlled trial
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
✍ Olivier Vitton; Michael Gendreau; Judy Gendreau; Jay Kranzler; Srinivas G. Rao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio